Journals / Pamukkale Tıp Dergisi / 2022 / Cilt: 15 - Sayı: 2

Evaluation of adherence to medical treatment and lifestyle changes at coronary artery disease

Koroner arter hastalığı olanlarda medikal tedavi ve yaşam tarzı değişikliklerine uyumun değerlendirilmesi

Pages
239–250
Publication Date
2022-04-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The medium andhigh-income level positively affected

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: Adherence to medical treatment (MT) and lifestyle changes (LC) in secondary prevention for coronaryartery disease (CAD) reduces disease-related mortality and morbidity.
📊
Key Findings & Data:In this study, we aimed to investigate theparameters affecting compliance with MT and LC in patients with CAD.Material and method: A standardized questionnaire was applied to 396 consecutive patients who werediagnosed with CAD by performing coronary angiography for different reasons at least one year ago, to evaluateadherence.Results: 20.9% of the patients (n=83) were found to be non-adherent to LC, 42.4% (n=168) were intermediateadherent,and 36.6% (n=145) were adherent. 81.1% (n=321) of the patients were found to be fully adherentto MT.
💡
Conclusion & Impact:The medium andhigh-income level positively affected
🔬Design:Survey & Empirical Study
📍Scope:Comprehensive Sample
⚙️Variables:Yaşam tarzı değişikliklerine uyum · medikal tedaviye uyum · koroner arter hastalığı

Abstract

Purpose: Adherence to medical treatment (MT) and lifestyle changes (LC) in secondary prevention for coronaryartery disease (CAD) reduces disease-related mortality and morbidity. In this study, we aimed to investigate theparameters affecting compliance with MT and LC in patients with CAD.Material and method: A standardized questionnaire was applied to 396 consecutive patients who werediagnosed with CAD by performing coronary angiography for different reasons at least one year ago, to evaluateadherence.Results: 20.9% of the patients (n=83) were found to be non-adherent to LC, 42.4% (n=168) were intermediateadherent,and 36.6% (n=145) were adherent. 81.1% (n=321) of the patients were found to be fully adherentto MT. Male gender (CI:1.966, p=0.023), younger age (age, RA:0.958, p=0.002), performing coronary arterybypass grafting (CI:2.635, p=0.015) increased adherence to LC, conversely non-ST elevation myocardialinfarction/unstable angina pectoris (CI:0.344, p=0.001) and ST-elevation myocardial infarction/fatal arrhythmia(CI:0.472 p=0.014) decreased adherence. Presence of hypertension (CI:5,779, p<0.001), ST-elevationmyocardial infarction/fatal arrhythmia (CI:3.736, p=0.029) increased adherence to MT but percutaneouscoronary intervention (CI:0.132, p=0.002) decreased adherence to MT.Conclusion: Adherence to MT is higher than LC in patients with CAD in our study population. Youngermale patients were more adherent to LC but this effect was not observedadherence to LC. The medium andhigh-income level positively affected

Özet

Amaç: Koroner arter hastalığı (KAH) için sekonder korumada medikal tedavi (MT) yaşam tarzı değişikliklerine(YTD) uyum hastalığa bağlı mortalite ve morbiditeyi azaltmaktadır. Bu çalışmada KAH hastalarında MT veYTD’ye uyumu etkileyen parametrelerin araştırılması amaçlanmıştır.Gereç ve yöntem: En az bir yıl önce farklı sebeplerle koroner anjiografi yapılarak KAH tanısı almış ardışık 396hastaya uyumu değerlendirmek üzere standardize edilmiş anket uygulanmıştır.Bulgular: Hastaların %20,9’u (n=83) YTD’ye uyumsuz, %42,4’ü (n=168) orta derecede uyumlu, %36,6’sı(n=145) uyumlu saptanmıştır. %81,1’i ise (n=321) MT’ye tam uyumlu saptanmıştır. Erkek cinsiyet (RA:1,966,p=0,023), daha genç yaş (yaş, RA:0,958, p=0,002), KABG yapılması YTD’ye uyumu arttırırken (RA:2,635,p=0,015), ST elevasyonsuz miyokart enfarktüsü/unstabil angina pektoris nedeniyle koroner anjiografi yapılmışolması (RA:0,344, p=0,001) ve ST elevasyonlu miyokart enfarktüsü/ölümcül aritmi nedeniyle koroner anjiografiyapılmış olması (RA:0,472 p=0,014) YTD’ye tam uyumluluk üzerine negatif etkilidir. Hipertansiyon varlığı(RA:5,779 p<0,001), ST elevasyonlu miyokart enfarktüsü/ölümcül aritmi (RA:3,736, p=0,029) varlığı MT’yeuyumu arttırırken, perkütan koroner girişim uygulanması (RA:0,132, p=0,002) MT’ye uyumu azaltmaktadır.Sonuç: Ülkemizde KAH hastalarında MT’ye uyum YTD’ye uyumdan daha yüksektir. Genç yaş erkek hastalarYTD’ye daha fazla uyum sağlarken bu etki MT’de saptanmamıştır. Gelir düzeyinin orta ve yüksek olması YTD’neuyumu pozitif yönde etkilerken

🔖

Cite This Article

BÜBER, İ., SEVGİCAN, C. İ. (2022). Evaluation of adherence to medical treatment and lifestyle changes at coronary artery disease. Pamukkale Tıp Dergisi, Cilt: 15 - Sayı: 2, 239–250. https://ajindex.com/articles/696390

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. KAYNAKLAR 1. Hanna IR, Wenger NK. Secondary prevention of coronary heart disease in elderly patients. Am Fam Physician, 2005. 71(12): p. 2289-96. 2. Han E, Suh DC, Lee SM, Jang S. The impact of medication adherence on health outcomes for chronic metabolic diseases: a retrospective cohort study. Res Social Adm Pharm, 2014. 10(6): p. e87-e98. 3. Cutler RL, Fernandez-Llimos F, Frommer M, Benrimoj C, Garcia-Cardenas V. Economic impact of medication non-adherence by disease groups: a systematic review. BMJ Open, 2018. 8(1): p. e016982. 4. Melloni C, Alexander KP, Ou FS, LaPointe NM, Roe MT, Newby LK, et al., Predictors of early discontinuation of evidence-based medicine after acute coronary syndrome. Am J Cardiol, 2009. 104(2): p. 175-81. 5. Ho PM, Magid DJ, Shetterly SM, Olson KL, Maddox TM, Peterson PN, et al., Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease. Am Heart J, 2008. 155(4): p. 772-9. 6. Catapano AL, Graham I, De Backer G, Wiklund O, Chapman MJ, Drexel H, et al., 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias. Kardiol Pol, 2016. 74(11): p. 1234-1318. 7. Chen HY, Saczynski JS, Lapane KL, Kiefe CI, Goldberg RJ. Adherence to evidence-based secondary prevention pharmacotherapy in patients after an acute coronary syndrome: A systematic review. Heart Lung, 2015. 44(4): p. 299-308. 8. Jackevicius CA, Li P, Tu JV. Prevalence, predictors, and outcomes of primary nonadherence after acute myocardial infarction. Circulation, 2008. 117(8): p. 1028-36. 9. Lee YM, Kim RB, Lee HJ, Kim K, Shin MH, Park HK, et al., Relationships among medication adherence, lifestyle modification, and health-related quality of life in patients with acute myocardial infarction: a cross-sectional study. Health Qual Life Outcomes, 2018. 16(1): p. 100. 10. Franklin JM, Krumme AA, Shrank WH, Matlin OS, Brennan TA, Choudhry NK. Predicting adherence trajectory using initial patterns of medication filling. Am J Manag Care, 2015. 21(9): p. e537-44. 11. Lu M, Hravnak M, Ma J, Lin Y, Zhang X, Shen Y, et al., Prediction of Changes in Adherence to Secondary Prevention Among Patients With Coronary Artery Disease. Nurs Res, 2020. 69(5): p. E199-E207. 12. Lee HY, Cooke CE, Robertson TA. Robertson, Use of secondary prevention drug therapy in patients with acute coronary syndrome after hospital discharge. J Manag Care Pharm, 2008. 14(3): p. 271-80. 13. August KJ, Sorkin DH. Marital status and gender differences in manag